Business
Rakovina Therapeutics to Present at at The Emerging Growth Conference on June 23, 2021
Rakovina Therapeutics to Present at at The Emerging Growth Conference on June 23, 2021 ...
About this update from Rakovina Therapeutics Inc
[{"type":"text","content":"\n \n \n \n Rakovina Therapeutics to Present at at The Emerging Growth Conference on June 23, 2021\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\ntable p, #divContent table p\n{\nmargin: 0px;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n VANCOUVER, BC\n \n ,\n \n June 17, 2021\n \n /CNW/ - Rakovina Therapeutics Inc. (TSXV: RKV) (\"the Company\"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce that the Company has been invited to present at The Emerging Growth Conference on\n \n June 23, 2021\n \n .\n \n \n \n \n \n \n \n \n \n This live, interactive online event will give shareholders and the investment community the opportunity to interact with members of Rakovina Therapeutics' senior management in real time.\n \n \n Rakovina Therapeutics' presentation is scheduled for\n \n 2:30 pm Eastern time\n \n .  Rakovina Therapeutics executive chairman, Mr.\n \n Jeffrey Bacha\n \n will provide an overview of the company after which he and members of the company's senior management will be available for questions and discussion with the investment community.\n \n \n Interested participants are encouraged to register for the conference in advance at:\n \n \n https://goto.webcasts.com/starthere.jsp?ei=1473091&tp_key=f82736754c&sti=rkv\n \n \n \n An archived webcast will also be made available on\n \n EmergingGrowth.com\n \n and on the Rakovina Therapeutics website after the live event.\n \n \n \n \n About Rakovina Therapeutics Inc.\n \n \n \n \n Rakovina Therapeutics Inc., founded in 2020, is focused on the development of new cancer treatments based on novel DNA-damage response technologies. The Company has established a pipeline of DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration and similar international regulatory agencies. Further information may be found at\n \n www.rakovi...